Physician profile
Ronald Morton
NPI 1477537405
$1,286.10
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $140 · 2021: $160 · 2022: $252 · 2023: $51.05 · 2024: $42.18 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $496.05 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $356.28 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $119.70 | 2025 | Dupixent |
| Advanced Respiratory, INC | $83.60 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $39.12 | 2021-2022 | |
| Philips North America LLC | $38.12 | 2019-2024 | (Ak6) Vest Therapy |
| Baxter Healthcare | $31.62 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $29.55 | 2019-2020 | |
| Sarepta Therapeutics, INC. | $24.25 | 2024 | Elevidys |
| Tolmar, INC. | $18.18 | 2023 | |
| Ptc Therapeutics, INC. | $17.11 | 2023 | Emflaza |
| Chiesi USA, INC. | $16.76 | 2021 | |
| Genentech, INC. | $15.76 | 2023 | Evrysdi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.